Anna Brown

Reporter at Endpoints News, a Financial Times company

london, england, united kingdom

Publications:

cconcordmonitor.com

ddigital.kenyon.edu

eendpoints.news

tthe-reporter.cmsmasters.net

tthe-reporter.cmsmasters.studio

tthefordhamram.com

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

About

Graduated with a Distinction in MSc Biomedical Research at the University of Bristol (2021) and due to have my research published later this year (2023), following completing my BSc Biology with a 1st Class Honours.

Featured Articles

Exclusive: Trump administration appears to have ended its US trade probe into pharma

Exclusive: Trump administration appears to have ended its US trade probe into pharma The Department of Commerce appears to have concluded its Section 232 investigation into pharmaceutical imports, according to a new document reviewed by Endpoints News. …

endpoints.news•Anna Brown•Jan 13, 2026

AbbVie reaches MFN deal with the White House, pledges billions to US manufacturing

AbbVie has struck a “most favored nation” deal with the White House to lower drug prices, the second-to-last of the 17 pharma companies to reach …

endpoints.news•Anna Brown•Jan 13, 2026

FDA shares eased manufacturing rules for cell and gene therapies

January 12, 2026 01:04 PM EST Cell/Gene TxFDA+Manufacturing FDA shares ‘more flexible approach’ to overseeing cell and gene therapy manufacturing Anna Brown News Reporter Sign up to read this article for free. Get free access to a limited number of articl... See more

endpoints.news•Anna Brown•Jan 12, 2026

Novartis to build fourth US radiotherapy factory in Florida

Novartis to build fourth US radiotherapy factory in Florida Novartis is building a new radioligand therapy factory in Florida as part of the company’s $23 billion US manufacturing pledge. The 35,000-square-foot facility in Winter …

endpoints.news•Anna Brown•Jan 9, 2026

J&J strikes drug pricing, tariff deal with the White House

Johnson & Johnson is the latest drugmaker to reach a”most favored nation” deal with the White House, agreeing to lower drug prices in the US …

endpoints.news•Anna Brown•Jan 9, 2026

Bylined Articles

HARO Queries

Portfolio

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Social Media

Pitching Guidelines

Keep it short (under 200 words)
Include credentials and links
Use subject lines with query title

Pitching Guidelines

Quick Stats

Followers

667

Articles77

Last Article2 hours ago

Stats

Education

Bachelor Of Science, Biology at University Of BristolGraduated: 2020

Art at University Of The Arts LondonGraduated: 2017

Education

Anna Brown

Is this you?

About

Featured Articles

Exclusive: Trump administration appears to have ended its US trade probe into pharma

AbbVie reaches MFN deal with the White House, pledges billions to US manufacturing

FDA shares eased manufacturing rules for cell and gene therapies

Novartis to build fourth US radiotherapy factory in Florida

J&J strikes drug pricing, tariff deal with the White House

Is this you?

Social Media

Education

Connect with journalists.

Connect with journalists.

Featured Articles

Exclusive: Trump administration appears to have ended its US trade probe into pharma

AbbVie reaches MFN deal with the White House, pledges billions to US manufacturing

FDA shares eased manufacturing rules for cell and gene therapies

Novartis to build fourth US radiotherapy factory in Florida

J&J strikes drug pricing, tariff deal with the White House

Social Media

Education